1 Department of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA 2 Department of Radiology, UT Southwestern Medical Center, Dallas, Texas, USA Correspondence to Dr Christopher ...
D Schartz1, A Finkelstein1, S Akkipeddi2, N Ellens2, P Valdes Barrera2, Z Williams3, E Vates2, M Bender2 1 Imaging Sciences, University of Rochester Medical Center, Rochester, NY 2 Neurosurgery, ...
Correspondence to Dr W Brinjikji, Department of Radiology, Mayo Clinic, 200 First Street SW, OL1-112 SMH, Rochester, MN 55905, USA; Brinjikji.waleed{at}mayo.edu Spinal epidural arteriovenous fistulas ...
Correspondence to Professor Hon-Man Liu, Medical Imaging, National Taiwan University Hospital, Taipei 10016, Taiwan; hmliu{at}ntu.edu.tw Cerebral hyperperfusion syndrome (CHS) is a clinical syndrome ...
Introduction Endovascular aneurysm treatment by flow diversion has classically relied on dual anti-platelet therapy with Aspirin and Plavix to reduce thrombotic complications. The heterogenous Plavix ...
Correspondence to Dr Justin F Fraser, Neurological Surgery, University of Kentucky, Lexington, KY 40536, USA; Jfr235{at}uky.edu ...
Background The transradial approach for cardiac catheterization is associated with improved patient safety and satisfaction in comparison with the transfemoral approach. Prospective data for the ...
Background and purpose We aimed to identify the best definition of early neurological improvement (ENI) at 2 and 24 hours after mechanical thrombectomy (MT) and determine its ability to predict a good ...
Correspondence to Dr Vivien H Lee, Neurology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; vivien.lee{at}osumc.edu Background We sought to determine the rate of early ...
Background The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to ...
Background Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology ...
Background Neo-intimal hyperplasia (NIH) is frequently observed after flow-diverter stent (FDS) implantation. Although mostly asymptomatic, this vascular response can sometimes lead to delayed ...